
New Biotechnology, Journal Year: 2023, Volume and Issue: 78, P. 76 - 83
Published: Oct. 10, 2023
Antibody therapeutics show great potential to treat a variety of diseases. Often, the dose that can be safely administered is limited by side effects arise from interaction with target outside diseased tissue. Conditionally-active antibodies provide an additional layer selectivity improve safety. Distinct external stimuli or internal cues enable different control strategies and applications. However, current antibody masking have low transferability across stimuli. Here we propose versatile approach conditionally mask derivatives its application single chain variable fragment (scFv) against receptor expressed on cancer stem cells in several tumours. Our strategy relies site-specific conjugation polymer engineered cysteine residue through chemically-synthesised linker cleaved response stimulus. We efficiency depends site size mask. An optimised decreases antigen binding up 20-fold affinity fully recovered upon activation exposure light at 365 nm incubation matrix metalloproteinases overexpressed solid This opens possibility rapidly engineer activatable any
Language: Английский